Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)

Cancer Causes and Control

Volumn 13, Issue 7, 2002, Pages 675-682

  Tran, Tina P ^a   Titus Ernstoff, Linda ^b   Perry, Ann E ^b   Ernstoff, Marc S ^b   Newsham, Irene F ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Dysplastic nevus; Loss of heterozygosity; Melanoma; P16

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; CYTOLOGY; DYSPLASTIC NEVUS; EARLY CANCER; EXON; FEMALE; GENE DELETION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOGENESIS; MELANOMA; NEVUS; POLYMORPHIC LOCUS; PRECURSOR; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; BIOPSY, NEEDLE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; CULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; GENES, P16; GENETIC MARKERS; HUMANS; LINEAR MODELS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEVUS, PIGMENTED; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; UNITED STATES;

EID: 0036713522     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019599629895     Document Type: Article

References (28)

1. The current situation with regard to human melanoma and genetic inferences
2. Malignant melanoma: Modern black plague and genetic black box
3. A cell cycle regulator potentially involved in genesis of many tumor types
4. INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
5. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas
6. Homozygous deletions within human chromosome band 9p21 in melanoma
7. INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma
8. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi
9. INK4 in sporadic melanoma
10. INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma
11. INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
12. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
13. INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma
14. An overview of the epidemiology of cutaneous melanoma
15. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas
16. INK4a and p53 genes in sporadic dysplastic nevus
17. Allelic deletion at chromosome 9p21 (p16) and 17p13 (p53) in microdissected sporadic dysplastic nevus
18. Malignant melanoma arising from nevi, p53, p16, and Bcl-2: Expression in benign versus malignant components
19. Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma
20. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
21. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
22. Precursors to malignant melanoma
23. Association of early malignant melanoma with nevocytic nevi
24. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
25. INK4A) in microdissected melanoma metastases by sequencing, and microsatellite and methylation screening
26. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development
27. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas